The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.37

Today's change-0.05 -2.19%
Updated May 6 1:28 PM -4GMT. Delayed by at least 15 minutes.
 

Applied DNA Sciences Inc

Nasdaq: APDN
Last

(U.S.) $2.37

Today's change-0.05 -2.19%
Updated May 6 1:28 PM -4GMT. Delayed by at least 15 minutes.

Applied DNA Sciences Inc down (U.S.)$0.05

Applied DNA Sciences Inc is sharply lower today, dropping (U.S.)$0.05 or 2.19% to (U.S.)$2.37. Over the last five days, shares have lost 9.83% and are down 18.10% for the last year to date. This security has underperformed the S&P 500 by 79.10% during the last year.

Key company metrics

  • Open(U.S.) $2.46
  • Previous close(U.S.) $2.42
  • High(U.S.) $2.49
  • Low(U.S.) $2.34
  • Bid / Ask(U.S.) $2.34 / (U.S.) $2.37
  • YTD % change-18.10%
  • Volume28,830
  • Average volume (10-day)58,920
  • Average volume (1-month)95,613
  • Average volume (3-month)116,262
  • 52-week range(U.S.) $2.02 to (U.S.) $8.28
  • Beta2.01
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.00
Updated May 6 1:28 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX1.18%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014Mar 31, 201403/31/2014
Revenue1111
Total other revenue--------
Total revenue1111
Gross profit--------
Total cost of revenue--------
Total operating expense5334
Selling / general / administrative5333
Research & development0000
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-4-3-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-8-2-2-3
Income after tax-8-2-2-3
Income tax, total--000
Net income-8-2-2-3
Total adjustments to net income--------
Net income before extra. items-8-2-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-8-2-2-3
Inc. avail. to common incl. extra. items-8-2-2-3
Diluted net income-8-2-2-3
Dilution adjustment--000
Diluted weighted average shares15141413
Diluted EPS excluding extraordinary itemsvalue per share-0.51-0.15-0.14-0.20
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share-0.51-0.15-0.14-0.20